PharmaCielo
PharmaCielo operates a large greenhouse and processing facility in Colombia, producing various cannabis extracts. The company is headquartered in Canada and publicly traded on TSXV and OTC markets.
Overview of PharmaCielo
PharmaCielo is a cannabis company headquartered in Canada with extensive operations in Colombia. The company operates a 12-hectare open-air greenhouse and a 2000 m2 processing and manufacturing facility in the Rionegro region of Colombia. Its comprehensive infrastructure allows for the production of up to 500,000 kg of flower annually, facilitated by four full crop cycles yearly. PharmaCielo employs over 400 people and ensures product quality through a state-of-the-art quality assurance laboratory. The company has been licensed in Colombia since 2016 and is publicly traded on the TSXV under the symbol PCLO and on the OTC under the symbol PCLOF.
PharmaCielo Services
PharmaCielo specializes in the production of a variety of cannabis extracts. These include full spectrum, broad spectrum, and pure CBD isolates, as well as water-soluble cannabinoids. The company's advanced processing and manufacturing capabilities enable it to provide these high-quality products, tailored to meet diverse client needs. License permits the production of both CBD-dominant and THC-dominant extracts, ensuring a wide array of applications for their cannabis-derived products. The company's services are backed by rigorous quality assurance practices, ensuring the highest standards in each phase of the extraction process.
PharmaCielo Facilities
PharmaCielo's facilities in the Rionegro region of Colombia encompass a 12-hectare open-air greenhouse and a 2000 m2 processing and manufacturing center. The company leverages these state-of-the-art facilities to produce up to 500,000 kg of flower annually, with four complete crop cycles each year. Additionally, the company maintains a modern quality assurance laboratory, integral to monitoring and ensuring the integrity of the extraction process. This substantial infrastructure supports PharmaCielo's commitment to producing high-quality cannabis extracts.
PharmaCielo Products
PharmaCielo offers an extensive range of cannabis extracts to cater to different market needs. The product lineup includes full spectrum and broad spectrum extracts, pure CBD isolates, and innovative water-soluble cannabinoids. These products are derived from the company's high-capacity, efficiently managed operations in Colombia. PharmaCielo's licensing allows for the production of both CBD-dominant and THC-dominant extracts, enabling a broad market reach and a diversified product portfolio that aligns with various customer requirements.
PharmaCielo Recognition
In 2020, PharmaCielo was recognized as a 'Project of National Strategic Interest' by the Colombian government. This designation underscores the company's significant role in the country's economic and industrial landscape. PharmaCielo's operations in Colombia began in earnest following the receipt of its manufacturing license in 2016. This recognition highlights the company's innovation, strategic importance, and contribution to the national economy through its substantial production capacities and workforce.